Hoth Therapeutics (HOTH), a New York-based biopharmaceutical company, announces IP advancements with expanded patent applications for its therapeutic pipeline.
The new patents highlight Hoth's dedication to developing innovative treatments, improving efficacy, and expanding applications for unmet medical needs.
The company invests in research and development to protect and grow its technologies, focusing on advancing its pipeline and delivering impactful healthcare solutions.
HOTH is currently trading at $1.3901 or 7.3267% lower on the Nasdaq Capital Market.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.